Clinical Trials

Accrual Status
Limit to SWOG Trials

1032 Results

View
Closed
Phase
Accrual
77%
Published
SWOG Clinical Trial Number
SWOG-8748

Alternating Induction Chemotherapy with Weekly Adriamycin and 5-Fluorouracil/Leucovorin Followed by Adriamycin and Cyclophosphamide, a Phase II Study in Poor Risk, Stage IV Breast Cancer
Activated
07-15-1988
Closed
03-01-1990
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8720

Evaluation of Amonafide in Pancreatic Adenocarcinoma
Activated
07-01-1988
Closed
07-15-1990
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8805

Neoadjuvant Cisplatin and VP-16 Plus Concurrent Chest and Optional Brain Irradiation for Patients with Stage lll Non-Small Cell Lung Carcinoma
Research Committee(s)
Lung Cancer
Activated
07-01-1988
Closed
03-15-1992
Closed
Phase
Accrual
59%
Published
SWOG Clinical Trial Number
SWOG-8738

Treatment of Extensive Non-Small Cell Lung Cancer: Standard Dose Cisplatin Versus High-Dose Cisplatin in Hypertonic Saline Alone Versus High-Dose Cisplatin/Mitomycin-C
Research Committee(s)
Lung Cancer
Activated
07-01-1988
Closed
06-01-1990
Closed
Phase
Accrual
83%
Published
SWOG Clinical Trial Number
SWOG-8760

A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Gastric Carcinoma
Activated
06-15-1988
Closed
01-01-1990
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8755

A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) In Patients With Pancreatic Adeno-carcinoma
Activated
06-15-1988
Closed
01-01-1990
Closed
Phase
Accrual
71%
Published
SWOG Clinical Trial Number
SWOG-8743

A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) In Patients with Metastatic Colorectal Adenocarcinoma
Activated
06-15-1988
Closed
01-01-1990
Closed
Phase
Accrual
63%
Published
SWOG Clinical Trial Number
SWOG-8717

Evaluation of Amonafide and Didemnin-B in the Treatment of Ovarian Cancer
Activated
05-15-1988
Closed
Phase
Accrual
57%
Published
SWOG Clinical Trial Number
SWOG-8726

Evaluation of Amonafide in Refractory Multiple Myeloma
Activated
04-01-1988
Closed
11-01-1989
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8800

Evaluation of Pibenzimol in Advanced Pancreatic Adenocarcinoma
Activated
04-01-1988
Closed
05-01-1989
Closed
Phase
Accrual
69%
Published
SWOG Clinical Trial Number
SWOG-8711

A Study of Reproductive Function in Patients with Testicular Cancer
Research Committee(s)
Genitourinary Cancer
Activated
04-01-1988
Closed
06-01-1994
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8804

Evaluation of Cis-Platinum and DTIC in Inoperable Stage lll and Stage IV Melanoma
Activated
04-01-1988
Closed
06-01-1990
Closed
Phase
Accrual
30%
Published
SWOG Clinical Trial Number
SWOG-8803

A Six Course Alternating Combination Regimen in Advanced Previously Untreated Head and Neck Cancer Patients
Activated
04-01-1988
Closed
05-01-1990
Closed
Phase
SWOG Clinical Trial Number
SWOG-8700

Consolidation Therapy with High-Dose Cyclophosphamide and Total Body Irradiation, Followed by Autologous Marrow Infusion in Metastatic Breast Cancer, Phase II
Research Committee(s)
Breast Cancer
Activated
04-01-1988
Closed
01-01-1989
Closed
Phase
Accrual
57%
SWOG Clinical Trial Number
SWOG-8735

A Phase II Study of Recombinant Human Interferon- Alpha and Recombinant Human Interferon-Gamma in Previously Untreated Patients with Chronic Myelogenous Leukemia
Activated
04-01-1988
Closed
05-15-1990
Closed
Phase
Accrual
23%
Published
SWOG Clinical Trial Number
SWOG-8706

A Prospective Study of Three Post-Remission Therapies in Adult Acute Nonlymphocytic Leukemia: Allogeneic Transplantation vs. Autologous Transplantation vs. Consolidation Chemotherapy
Research Committee(s)
Leukemia
Activated
04-01-1988
Closed
12-15-1990
Closed
Phase
Accrual
77%
Published
SWOG Clinical Trial Number
SWOG-8733

Evaluations of Operable Bladder Cancer Patients with Pre-Operative Irradiation + 5-FU and Inoperable Patients With Irradiation + 5-FU Alone, Phase II, A Pilot Study for Patients Ineligible for SWOG-8710
Research Committee(s)
Genitourinary Cancer
Activated
04-01-1988
Closed
02-15-1997
Closed
Phase
Accrual
92%
Published
SWOG Clinical Trial Number
SWOG-8810

Six Courses of 5-Fluorouracil and Cis-Platinum With Correlation of Clinical and Cellular DNA Parameters in Patients with Advanced, Untreated and Unresectable Squamous Cell Carcinoma of the Head and Neck
Activated
04-01-1988
Closed
12-15-1992
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8736 (INT-0093)

Treatment of Localized Non-Hodgkin's Lymphoma: Comparison of Chemotherapy (CHOP) to Chemo-therapy Plus Radiation Therapy
Research Committee(s)
Lymphoma
Activated
03-15-1988
Closed
06-15-1995
Closed
Phase
Accrual
97%
Published
SWOG Clinical Trial Number
SWOG-8515

Reactivated (unfavorable histology only): 4/15/90, Temporarily Closed (unfavorable histology only): 11/1/89 Evaluation of Menogaril (NSC-269148) in Non-Hodgkin's Lymphoma
Research Committee(s)
Lymphoma
Activated
03-15-1988
Closed
12-15-1991